OOIR: Observatory of International Research

Papers

(The median citation count of Molecular Carcinogenesis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
UBE2D1 promotes glioblastoma proliferation by modulating p21 ubiquitination	58
Issue Information ‐ Ed Board	34
The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway	32
Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer	31
Issue Information ‐ Ed Board	31
	29
IRF2BP2 drives lymphatic metastasis in OSCC cells by elevating mitochondrial fission‐dependent fatty acid oxidation	28
Thyroglobulin as a negative marker for malignancy in canine and human breast tumors	28
The Parkinson's disease‐associated protein α‐synuclein inhibits hepatoma by exosome delivery	28
Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle‐Invasive Bladder Cancer	27
Cover Image, Volume 62, Issue 4	26
Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells	26
RELA promotes the progression of oral squamous cell carcinoma via TFAP2A‐Wnt/β‐catenin signaling	25
PTPN2 Expression in Hypopharyngeal Squamous Cell Carcinoma and Its Clinical Significance	24
HNRNPC promotes estrogen receptor‐positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A‐dependent manner	24
Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer	24
Risk SNP‐mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway	23
Delta‐Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway	22
SIRT1 promotes doxorubicin‐induced breast cancer drug resistance and tumor angiogenesis via regulating GSH‐mediated redox homeostasis	21
Comprehensive analysis of PTEN‐related ceRNA network revealing the key pathways WDFY3‐AS2 ‐ miR‐21‐5p/miR‐221‐3p/miR‐222‐3p ‐ TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney rena	21
Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell‐specific molecule 1 expression	20
Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan	20
	20
Issue Information ‐ Ed Board	19
Issue Information ‐ Ed Board	19

Atypical BCR‐ABL1 transcript in mixed phenotype acute leukemia with bone marrow necrosis	19
ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β‐catenin pathway	18
Conditional deletion of mTOR discloses its essential role in early B‐cell development	18
Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma	18
	18
AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway	17
The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells	17
Homologous recombination repair gene mutations in colorectal cancer favors treatment of immune checkpoint inhibitors	17
Correction to “Cucurbitacin B Induces Inhibitory Effects via CIP2A/PP2A/Akt Pathway in Glioblastoma Multiforme”	17
YTHDF1 enhances stemness and chemoresistance in triple‐negative breast cancer cells by upregulating SIAH2	16
	15
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells	15
Intratumoural heterogeneity and clone evolution of oral squamous cell carcinoma	15
Transcriptional activation of S100A2 expression by HIF‐1α via binding to the hypomethylated hypoxia response elements in HCC cells	14
Oncogenic fusion of CD63‐BCAR4 contributes cancer stem cell‐like properties via ALDH1 activity	14
Issue Information ‐ Ed Board	14
VPS45 Contributes to the Progression of Hepatocellular Carcinoma by Triggering the Wnt/β‐Catenin Signaling Pathway	14
Identification of concurrent STAT3::RARA and RARA::STAT5b fusions in a variant APL case	14
Circ_0007429/miR‐637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC	13
Transmembrane protein 147, as a potential Sorafenib target, could expedite cell cycle process and confer adverse prognosis in hepatocellular carcinoma	13
Role of solute carrier transporters SLC25A17 and SLC27A6 in acquired resistance to enzalutamide in castration‐resistant prostate cancer	12
Potential Crosstalk Between ANXA1+ Epithelial Cells and FABP4+ TAM Cells of Ferroptosis‐Related Molecular Clusters Promotes an Immunosuppressive Microenvironment in Non‐Small Cell Lung Cancer	12
DNTT activation, TdT‐aided gene length mutation, and better prognosis in ATG‐based regimen allo‐HSCT in AML	12
	12
Plakophilin 1 in carcinogenesis	12
A potential signaling axis between RON kinase receptor and hypoxia‐inducible factor‐1 alpha in pancreatic cancer	12
Immunomodulatory role of thrombin in cancer progression	12
	12
Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype	12
Associations of genetically predicted circulating insulin‐like growth factor‐1 and insulin‐like growth factor binding protein‐3 with bladder cancer risk	11
β‐Elemene Inhibits Adrenocortical Carcinoma Cell Proliferation and Migration, and Induces Apoptosis by Up‐Regulating miR‐486‐3p/Targeting NPTX1 Axis	11
Divergence of mutational signatures in association with breast cancer subtype	11
Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer	11
LATS‐regulated nuclear‐cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial–mesenchymal transition	11
Role of hemoglobin alpha and hemoglobin beta in non‐small‐cell lung cancer based on bioinformatics analysis	11
HMGB3 Contributes to Anti‐PD‐1 Resistance by Inhibiting IFN‐γ‐Driven Ferroptosis in TNBC	11
Tissue‐of‐origin for cancers determines HIF‐1 activation induced phenotypic heterogeneity	11
HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer	11
Issue Information ‐ Ed Board	11
Levels of Bile Acid Metabolism Are Associated With Alterations of Gut Microbes in Hepatocellular Carcinoma	10
Imatinib Impedes EMT and Notch Signalling by Inhibiting p300 Acetyltransferase in Breast Cancer Cells	10
Upregulation of collagen type X alpha 1 promotes the progress of triple‐negative breast cancer via Wnt/β‐catenin signaling	10
PARP5B is required for nonhomologous end joining during tumorigenesis in vivo	10
Retraction	10
SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway	10
Stage‐specific differential expression of zinc transporter SLC30A and SLC39A family proteins during prostate tumorigenesis	10
KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM2	10
Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5	10
M2 macrophage exosome‐derived Apoc1 promotes ferroptosis resistance in osteosarcoma by inhibiting ACSF2 deubiquitination	10
Doublecortin‐like kinase 1 is a therapeutic target in squamous cell carcinoma	10

Computed Tomography‐Based Radiomics and Genomics Analyses for Survival Prediction of Stage III Unresectable Non‐Small Cell Lung Cancer Treated With Definitive Chemoradiotherapy and Immunotherapy	9
Integrative Bioinformatics Analysis and Experimental Study of NLRP12 Reveal Its Prognostic Value and Potential Functions in Ovarian Cancer	9
The JAK3^Q988P mutation reveals oncogenic potential and resistance to ruxolitinib	9
	9
Cover Image, Volume 62, Issue 2	9
	9
Low expression of lncRNA SBF2‐AS1 regulates the miR‐302b‐3p/TGFBR2 axis, promoting metastasis in laryngeal cancer	9
Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell‐like properties and phosphoinositide 3‐kinas	9
Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF‐κB pathway, and elevated MMP13 expression	9
Issue Information ‐ Ed Board	9
Review: PD‐L1 as an emerging target in the treatment and prevention of keratinocytic skin cancer	9
Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells	9
A variant in CYP26B1 associated with esophageal squamous cell carcinoma risk by affecting retinoic acid metabolism	9
Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients	9
A‐to‐I‐Edited miR‐1304‐3p Inhibits Glycolysis and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inactivating Wnt5a/ROR2 Signaling	9
	8
Association of SIRT6 Expression With Risk of Pneumonitis Induced by Radiotherapy in Cancer Patients	8
HER3 V104 mutations regulate cell signaling, growth, and drug sensitivity in cancer	8
Issue Information ‐ Ed Board	8
Genetic variations associated with telomere length predict the risk of recurrence of non‐oropharyngeal head and neck squamous cell carcinoma	8
Energy balance‐related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status	8
Mitogen‐activated protein kinase‐activated protein kinase‐2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer	8
The HDAC2–MTA3 interaction induces nonsmall cell lung cancer cell migration and invasion by targeting c‐Myc and cyclin D1	8
Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression	8
The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma	8
A systems biology‐based approach to screen key splicing factors in hepatocellular carcinoma	8
Loss of PTPRS elicits potent metastatic capability and resistance to temozolomide in glioblastoma	8
Issue Information ‐ Ed Board	8
MicroRNA‐505‐5p/‐3p Regulates the Proliferation, Invasion, Apoptosis, and Temozolomide Resistance in Mesenchymal Glioma Stem Cells by Targeting AUF1	7
circEIF3I Promotes Colorectal Cancer Metastasis by Regulating the miR‐328‐3p/NCAPH Axis	7
Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer	7
TP53 mutations in head and neck cancer	7
	7
Deciphering CD4⁺ T cell‐mediated responses against cancer	7
KCNE3 Facilitates M1 Macrophage Polarization by Suppressing the Wnt/β‐Catenin Pathway, Inhibiting Glioma Proliferation, Migration, and Invasion	7
GRP78 promotes bone metastasis of prostate cancer by regulating bone microenvironment through Sonic hedgehog signaling	7
Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression	7
Transcriptome profiling reveals that VNPP433‐3β, the lead next‐generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial–mesenchymal transition and stem cell marker	7
Benzo[a]pyrene diol epoxide‐induced transformed cells identify the significance of hsa_circ_0051488, a ERCC1‐derived circular RNA in pulmonary squamous cell carcinoma	7
Triiodothyronine (T3) suppresses hepatic tumorigenesis and development by inhibiting the phosphorylation of ERK	7
TRIM16 E121D variant affects the risk and prognosis of hepatocellular carcinoma by modulating the Wnt/β‐catenin pathway	7
Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy	7
Corrigendum	7
BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial‐mesenchymal transition and hepatic stellate cells	7
Baicalein promotes KDM4E to induce BICD1 and inhibit triple‐negative breast cancer progression by blocking PAR1 signaling	7
HIF‐1α regulates the cell viability in radioiodine‐resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF‐κB signaling pathway	7
Corrigendum	7
	7
Associations of mitochondrial DNA copy number with incident risks of gastrointestinal cancers: A prospective case–cohort study	6
KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation	6
Dysregulated BCL9 Controls Tumorigenicity and Ferroptosis Susceptibility by Binding With Nrf2 in Thyroid Carcinoma	6
SRPK1 Activation Facilitates Gli3^S664 Phosphorylation and Promotes Metastasis in Esophageal Squamous Cell Carcinoma	6
HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway	6
γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway	6
Corrigendum	6
	6
ZNF480 Accelerates Chemotherapy Resistance in Breast Cancer by Competing With TRIM28 and Stabilizing LSD1 to Upregulate the AKT‐GSK3β‐Snail Pathway	6
Lesser prevalence of polyps/WNT‐dysregulation and concomitant upregulation of gamma‐catenin/MYC point to alternate pathways in colorectal cancer in India	6
CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c‐Raf/p‐MEK/p‐ERK signaling loop	6
CircSPAG16 suppresses cadmium‐induced transformation of human bronchial epithelial cells by decoying PIP5K1α to inactivate Akt	6
SIRT1 inhibition‐induced senescence as a strategy to prevent prostate cancer progression	6
Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling	6
	6
TMED3 stabilizes SMAD2 by counteracting NEDD4‐mediated ubiquitination to promote ovarian cancer	6
CD137 Protein Expression Pattern Determines the Functional Role of Galectin‐9 in Colorectal Cancer	6
Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies	6
Pharmacologic approaches to amino acid depletion for cancer therapy	6
Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer	6
	6
circPPP2R4 promotes colorectal cancer progression and reduces ROS production through the miR‐646/FOXK1 axis	6
NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m⁵C‐dependent manner	6
Regulation of SELENOF translation by eIF4a3: Possible role in prostate cancer progression	6
Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis	6
microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2	6
ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway	6
Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk	5
Issue Information ‐ Ed Board	5
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma	5
Withaferin A mediated changes of miRNA expression in breast cancer‐derived mammospheres	5
ACKR3 orchestrates Hedgehog signaling to promote renal cell carcinoma progression	5

FOXD3 suppresses epithelial–mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma	5
Issue Information ‐ Ed Board	5
Hypoxia Promotes Malignant Progression of Colorectal Cancer by Inducing POSTN⁺ Cancer‐Associated Fibroblast Formation	5
Loss of SETD2‐mediated downregulation of intracellular and exosomal miRNA‐10b determines MAPK pathway activation and multidrug resistance in renal cancer	5
	5
	5
Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition	5
Characterizing Genetic Susceptibility to Colorectal Cancer in Taiwan Through Genome‐Wide Association Study	5
PKMYT1 induced by YAP/TEAD1 gives rise to the progression and worse prognosis of bladder cancer	5
CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1	5
BATF promotes extramedullary infiltration through TGF‐β1/Smad/MMPs axis in acute myeloid leukemia	5
Mass cytometry and transcriptomic profiling reveal PD1 blockade induced alterations in oral carcinogenesis	5
Expression of Concern: Amplification of Cyclinl1 in Uterine Cervical Carcinoma Has Prognostic Implications	5
Issue Information ‐ Ed Board	5
	5
Cover Image, Volume 63, Issue 5	5
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway	5
Tumor‐derived extracellular vesicles confer 5‐fluorouracil resistance in esophageal cancer via long noncoding RNA AC116025.2 delivery	5
A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle‐related genes and miRNAs in triple‐negative breast cancer cells	5
	5
Precision therapy for cancer prevention by targeting carcinogenesis	5
NUAK family kinase 2 is a novel therapeutic target for prostate cancer	5
Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway	4
Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1⁺INHBA⁺CAF as drivers of colorectal cancer progression	4
The efficacy and safety of pH‐responsive and photothermal‐sensitive multifunctional nanoparticles loaded with cryptotanshinone for the treatment of gastric cancer	4
Issue Information ‐ Ed Board	4
Daurisoline suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting MEK1/2 kinase	4
Downregulation of cellular retinoic acid binding protein 1 fosters epithelial–mesenchymal transition in thyroid cancer	4
FAP^high α‐SMA^low cancer‐associated fibroblast‐derived SLPI protein encapsulated in extracellular vesicles promotes ovarian cancer development via activation of PI3K/AKT and downs	4
KIN17 promotes cell migration and invasion through stimulating the TGF‐β/Smad2 pathway in hepatocellular carcinoma	4
Adipocytes Promote Endometrial Cancer Progression Through Activation of the SIRT1‐HMMR Signaling Axis	4
Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway	4
Issue Information ‐ Ed Board	4
GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma	4
Inhibiting Wnt/beta‐catenin in CTNNB1‐mutated endometrial cancer	4
	4
LncRNA FGD5‐AS1 Facilitates Hepatocellular Carcinoma Cell Stemness by Enhancing PKD1 mRNA Stability Through Binding With MSI2	4
Integrated Genomics Reveal Potential Resistance Mechanisms of PANoptosis‐Associated Genes in Acute Myeloid Leukemia	4
Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma	4
Autophagy awakens—the myriad roles of autophagy in head and neck cancer development and therapeutic response	4
	4
KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis	4
circSLC25A13 acts as a ceRNA to regulate AML progression via miR‐616‐3p/ADCY2 axis	4
CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple‐negative breast cancer by targeting miR‐761/DACT2 signaling axis	4
Molecular Analysis of Genes CEBPA, NPM1, IDH1, and RUNX1 Polymorphisms as Biomarker Potential in Leukemia Patients	4
G2 and S phase‐expressed‐1 induces chromosomal instability in esophageal squamous cell carcinoma cells and inhibits cell apoptosis through ROS/JNK signaling	4
JD‐02, a novel Hsp90 inhibitor, induces ROS/SRC axis‐dependent cytoprotective autophagy in colorectal cancer cells	4
Inhibition of endogenous hydrogen sulfide production suppresses the growth of nasopharyngeal carcinoma cells	4
Expression of Concern: Alterations of RASSF1A in Premalignant Cervical Lesions: Clinical and Prognostic Significance	4
Issue Information ‐ Ed Board	4
RNF7‐Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes	4
Glutamine, Serine and Glycine at Increasing Concentrations Regulate Cisplatin Sensitivity in Gastric Cancer by Posttranslational Modifications of KDM4A	4
Zinc Finger Protein 263 Augments Autophagy and Promotes Intrahepatic Cholangiocarcinoma Proliferation	4
Evaluation and Comparison of Prognostic Multigene Tests in Early‐Stage Breast Cancer: Which Is the Most Effective? A Literature Review Exploring Clinical Utility to Enhance Therapeutic Management in L	4
P21‐Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells	4
Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma	4
	4
FAP positive cancer‐associated fibroblasts promote tumor progression and radioresistance in esophageal squamous cell carcinoma by transferring exosomal lncRNA AFAP1‐AS1	4
The serine protease CORIN promotes progression of gastric cancer by mediating the ERK1/2 MAPK pathway	4
	4
PDZ‐binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathway	4
PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer	4
A comprehensive evaluation of serum tRF‐29‐R9J8909NF5JP as a novel diagnostic and prognostic biomarker for gastric cancer	4
ARMC10 Drives Glioblastoma Progression Through Activating Notch Pathway	4
Corrigendum	4
Rapalogs induce non‐apoptotic, autophagy‐dependent cell death in HPV‐negative TP53 mutant head and neck squamous cell carcinoma	4
Polymorphisms of acetaldehyde dehydrogenase 2 and alcohol dehydrogenase 1B on the malignant transformation of vocal cord leukoplakia: A Chinese cohort	3
Issue Information ‐ Ed Board	3
Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT‐mTOR pathway	3
DSN1 Interaction With Centromere‐Associated Proteins Promotes Chromosomal Instability in Hepatocellular Carcinoma	3
Issue Information ‐ Ed Board	3
Issue Information ‐ Ed Board	3
MiR‐15a‐3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer	3
	3
Issue Information ‐ Ed Board	3
Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells	3
Case report & review: Bilateral NIFTP harboring concomitant HRAS and KRAS mutation: Report of an unusual case and literature review	3
Cover Image, Volume 61, Issue 7	3
Cover Image, Volume 61, Issue 2	3
Cip2a induces arginine biosynthesis and promotes tumor progression in non‐small cell lung cancer	3
Issue Information ‐ Ed Board	3
Identification of ATAD3A as a key regulator in non‐small cell lung cancer by promoting STAT3‐induced cell proliferation and tumor angiogenesis	3
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas	3
Monocarboxylate transporter 1 is a novel target for breast cancer stem like‐cell inhibition by diallyl trisulfide	3
	3
Heterochiral dipeptide d‐phenylalanyl‐l‐phenylalanine (H‐^DPhe‐^LPhe‐OH) as a potential inducer of metastatic suppressor NM23H1 in p53 wild‐type and mutant ce	3
Feed‐forward activation of STAT3 signaling limits the efficacy of c‐Met inhibitors in esophageal squamous cell carcinoma (ESCC) treatment	3
Hsa_circ_0000231 Accelerates Cell Autophagy and Promotes Cell Proliferation and Invasion of Colorectal Cancer via miR‐140‐3p/Bcl‐2 Axis	3
Wogonin Inhibits Ovarian Cancer by Activating the AMPK‐TET2‐5hmC Axis	3
Corrigendum	3
Silmitasertib in Combination With Cabozantinib Impairs Liver Cancer Cell Cycle Progression, Induces Apoptosis, and Delays Tumor Growth in a Preclinical Model	3
Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B	3
RETRACTION: “LncAPC Drives Wnt/Β‐Catenin Activation and Liver TIC Self‐Renewal Through EZH2 Mediated APC Transcriptional Inhibition”	3
Valproic acid increased the efficacy of EGFR TKIs on EGFR/TP53 co‐mutated lung cancers and downregulated mutant‐p53 levels	3
GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma	3